Phase II study of nivolumab (anti-PD-1, BMS-936558, ONO-4538) in patients with advanced, refractory squamous non-small cell lung cancer Meeting Abstract
| Authors: | Ramalingam, S. S.; Mazieres, J.; Planchard, D.; Stinchcombe, T. E.; Dy, G. K.; Antonia, S. J.; Horn, L.; Lena, H.; Minenza, E.; Mennecier, B.; Otterson, G. A.; Campos, L. T.; Gandara, D. R.; Levy, B. P.; Nair, S. G.; Zalcman, G.; Wolf, J.; Baudelet, C.; Lestini, B. J.; Rizvi, N. A. |
| Abstract Title: | Phase II study of nivolumab (anti-PD-1, BMS-936558, ONO-4538) in patients with advanced, refractory squamous non-small cell lung cancer |
| Meeting Title: | 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology |
| Journal Title: | International Journal of Radiation Oncology, Biology, Physics |
| Volume: | 90 |
| Issue: | 5 |
| Meeting Dates: | 2014 Oct 30-Nov 1 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0360-3016 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2014-12-01 |
| Start Page: | 1266 |
| End Page: | 1267 |
| Language: | English |
| ACCESSION: | WOS:000346414500056 |
| PROVIDER: | wos |
| PUBMED: | 25539389 |
| DOI: | 10.1016/j.ijrobp.2014.09.038 |
| Notes: | Meeting Abstract -- Chicago Multidisciplinary Symposium in Thoracic Oncology -- OCT 30-NOV 01, 2014 -- Chicago, IL -- Source: Wos |
